Dominick J. Angiolillo

Internal Medicine
15255 Max Leggett Pkwy Ste 3600
Jacksonville, FL 32218

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 653 publications

Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.

Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.

Journal: The New England journal of medicine
Published: August 31, 2026

Pretreatment with P2Y12 inhibitors in Acute and Chronic Coronary Syndromes: for whom, when and how.

Pretreatment with P2Y12 inhibitors in Acute and Chronic Coronary Syndromes: for whom, when and how.

Journal: The American journal of medicine
Published: August 10, 2026

Bivalirudin in Primary PCI: Time to Implement the Overwhelming Evidence?

Bivalirudin in Primary PCI: Time to Implement the Overwhelming Evidence?

Journal: Journal of the American College of Cardiology
Published: July 07, 2026

Prasugrel should be preferred over ticagrelor in acute coronary syndromes: pros and cons.

Prasugrel should be preferred over ticagrelor in acute coronary syndromes: pros and cons.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: May 15, 2026

De-escalation of antiplatelet therapy to evaluate platelet reactivity and clinical outcomes after coronary stenting in patients at high bleeding risk and recent acute coronary syndrome: Rationale and design of the DESC-HBR trial.

De-escalation of antiplatelet therapy to evaluate platelet reactivity and clinical outcomes after coronary stenting in patients at high bleeding risk and recent acute coronary syndrome: Rationale and design of the DESC-HBR trial.

Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: May 11, 2026

2025 Acute Coronary Syndrome Guideline: Missing the Boat on CYP2C19 Genotyping.

2025 Acute Coronary Syndrome Guideline: Missing the Boat on CYP2C19 Genotyping.

Journal: Journal of the American Heart Association
Published: May 06, 2026

Increased Platelet FcɣRIIa Identifies Patients at Greater Risk of Multiple Cardiovascular Events After Myocardial Infarction.

Increased Platelet FcɣRIIa Identifies Patients at Greater Risk of Multiple Cardiovascular Events After Myocardial Infarction.

Journal: JACC. Advances
Published: April 27, 2026

Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention.

Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention.

Journal: European journal of preventive cardiology
Published: April 20, 2026

Effect of Dapagliflozin on Myocardial Fibrosis After STEMI: A Double-Blind, Placebo-Controlled Randomized Trial.

Effect of Dapagliflozin on Myocardial Fibrosis After STEMI: A Double-Blind, Placebo-Controlled Randomized Trial.

Journal: Journal of clinical medicine
Published: April 15, 2026

Pharmacodynamics of Early vs Delayed Ticagrelor Loading During Cangrelor Infusion in ST-Segment Elevation Myocardial Infarction.

Pharmacodynamics of Early vs Delayed Ticagrelor Loading During Cangrelor Infusion in ST-Segment Elevation Myocardial Infarction.

Journal: JACC. Cardiovascular interventions
Published: April 02, 2026

Machine Learning With Genetic and Clinical Data to Predict Ischemic Outcomes After PCI.

Machine Learning With Genetic and Clinical Data to Predict Ischemic Outcomes After PCI.

Journal: Clinical and translational science
Published: April 02, 2026

Aspirin Withdrawal in Patients With Coronary Artery Disease.

Aspirin Withdrawal in Patients With Coronary Artery Disease.

Journal: Journal of the American College of Cardiology
Published: March 23, 2026
Showing 1-12 of 653

Last Updated: 09/26/2026